- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
The Cooper Companies, Inc(COO)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for COO
11/13/2026: COO (1-star) is currently NOT-A-BUY. Pass it for now.
The Cooper Companies is a specialized medical device company operating through its CooperVision and CooperSurgical segments. The company benefits from a solid position in high-demand recurring categories like silicone hydrogel contact lenses and fertility treatments. Its primary growth story revolves around product innovation in daily disposables and pediatric myopia management, though it faces intense competition from larger medtech giants and foreign exchange headwinds. The stock suits growth-oriented healthcare investors who can tolerate moderate valuation and integration risks. Key developments to monitor include margin trends, debt reduction, and the adoption rate of MiSight.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit while signal remains positive | The company captures secular demand tailwinds in specialty eye care and reproductive medicine. |
| Momentum investor | Mixed fit | Momentum fit is conditional on positive technical breakout signals and relative strength confirmation. |
| Value investor | Mixed fit | The stock trades at normalized healthcare multiples that require careful valuation discipline. |
| Dividend investor | Weak fit | Cooper prioritizes reinvesting cash flows into business expansion over substantial dividend payouts. |
| Low-risk investor | Medium | While healthcare demand is defensive, currency fluctuations and integration risks introduce moderate volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock experiences standard equity fluctuations tied to broader market sentiment and quarterly healthcare results. |
| Valuation risk | Medium | Forward multiples leave minimal room for operational disappointment during slower economic periods. |
| Competition risk from global medtech enterprises | Medium / high | Aggressive rivals like Alcon and Johnson & Johnson constantly challenge market share in contact lenses. |
| Business quality | Strong | High customer retention and repeat-use consumables underpin a solid economic franchise. |
| Dividend income | Low / none | Income-focused investors will find negligible yield due to capital reinvestment policies. |
| Execution risk | Medium | Successful integration of large acquisitions is crucial for achieving projected synergy targets. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.91B USD | Price to earnings Ratio 21.53 | 1Y Target Price 65.8 |
Price to earnings Ratio 21.53 | 1Y Target Price 65.8 | ||
Volume (30-day avg) 3.0M shares | Beta 0.82 | 52 Weeks Range 51.01 - 89.83 | Updated Date 11/15/2026 |
52 Weeks Range 51.01 - 89.83 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.91 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.7%
- Active BUY / eligible
- 69 / 110
- 30-Day BUY Count Change
- +30
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Instruments & Supplies
- BUY participation
- 60.0%
- Active BUY / eligible
- 3 / 5
- 30-Day BUY Count Change
- +1
Eligible universe: 5 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Downtrend
The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit 6.25% | Avg. Invested days 47 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| CooperVision (Contact Lenses) | Global sales of daily, two-week, and monthly soft contact lenses including silicone hydrogel, toric, and multifocal variants. | This is the primary revenue engine benefiting from recurring replacement demand by everyday contact lens wearers. |
| CooperSurgical (Medical Devices & Fertility) | IVF media, genomic testing, surgical instruments, and cryostorage/donor services for women's health clinics. | Provides higher-margin specialized exposure to growing global fertility treatment trends. |
| Geographic Exposure | Commercial operations spanning the Americas, Europe, Middle East, Africa, and Asia-Pacific regions. | Offers balanced international diversification while exposing earnings to foreign currency fluctuations. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 21.53 | Forward PE 12.84 | Enterprise Value 14.30B | Price to Sales(TTM) 2.81 |
Enterprise Value 14.30B | Price to Sales(TTM) 2.81 | ||
Enterprise Value to Revenue 3.38 | Enterprise Value to EBITDA 15.29 | Shares Outstanding 190.16M | Shares Floating 188.77M |
Shares Outstanding 190.16M | Shares Floating 188.77M | ||
Percent Insiders 1.94 | Percent Institutions 106.31 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

